Critical analysis of graft loss and death in kidney transplant recipients treated with mTOR inhibitors
J. bras. nefrol; 39 (1), 2017
Abstract Registry studies and systematic reviews have shown higher risk for mortality and graft loss in patients in use of mTOR inhibitors (mTORi) compared to calcineurin-based (CNI) immunosuppressive regimens. The majority of these studies pooled data from early trials using different strategies such as...